BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sharma R, Sharma A, Kambhampati SP, Reddy RR, Zhang Z, Cleland JL, Kannan S, Kannan RM. Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation. Bioeng Transl Med 2018;3:87-101. [PMID: 30065965 DOI: 10.1002/btm2.10094] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun Y, Li L, Chen Z, Yin X, Yang W, Chen Y, Liu Y. Scale inhibition performance of calcium sulfate by 1,6-diaminohexane-contained polyaminoamide dendrimers: Static experiment and MD simulation. Journal of Industrial and Engineering Chemistry 2022. [DOI: 10.1016/j.jiec.2022.07.049] [Reference Citation Analysis]
2 Gusdon AM, Faraday N, Aita JS, Kumar S, Mehta I, Choi HA, Cleland JL, Robinson K, McCullough LD, Ng DK, Kannan RM, Kannan S. Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial. Sci Transl Med 2022;14:eabo2652. [PMID: 35857827 DOI: 10.1126/scitranslmed.abo2652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
3 Khan NH, Mir M, Qian L, Baloch M, Ali Khan MF, Rehman A, Ngowi EE, Wu D, Ji X. Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures. Journal of Advanced Research 2022;36:223-47. [DOI: 10.1016/j.jare.2021.06.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Tallon C, Sharma A, Zhang Z, Thomas AG, Ng J, Zhu X, Donoghue A, Schulte M, Joe TR, Kambhampati SP, Sharma R, Liaw K, Kannan S, Kannan RM, Slusher BS. Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis. Neurotherapeutics 2022. [PMID: 34984651 DOI: 10.1007/s13311-021-01159-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
5 Hollinger KR, Sharma A, Tallon C, Lovell L, Thomas AG, Zhu X, Wiseman R, Wu Y, Kambhampati SP, Liaw K, Sharma R, Rojas C, Rais R, Kannan S, Kannan RM, Slusher BS. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis. Nanotheranostics 2022;6:126-42. [PMID: 34976589 DOI: 10.7150/ntno.63158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Modi HR, Wang Q, Olmstead SJ, Khoury ES, Sah N, Guo Y, Gharibani P, Sharma R, Kannan RM, Kannan S, Thakor NV. Systemic administration of dendrimer N‐acetyl cysteine improves outcomes and survival following cardiac arrest. Bioengineering & Transla Med 2022;7. [DOI: 10.1002/btm2.10259] [Reference Citation Analysis]
7 Sharma A, Sah N, Kannan S, Kannan RM. Targeted drug delivery for maternal and perinatal health: Challenges and opportunities. Adv Drug Deliv Rev 2021;177:113950. [PMID: 34454979 DOI: 10.1016/j.addr.2021.113950] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lee J, Park S, Kwon Y, Oh E, Kim DW, Guim H, Yeon J, Kim J, Choi JS. Synthesis and Characterization of Dual-Sensitive PAMAM Derivatives Conjugated with Enzyme Cleavable Peptides as Gene Carriers. Macromol Res 2021;29:636-47. [DOI: 10.1007/s13233-021-9078-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharma R, Liaw K, Sharma A, Jimenez A, Chang M, Salazar S, Amlani I, Kannan S, Kannan RM. Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma. J Control Release 2021;337:179-92. [PMID: 34274384 DOI: 10.1016/j.jconrel.2021.07.018] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 DeRidder L, Sharma A, Liaw K, Sharma R, John J, Kannan S, Kannan RM. Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances β-amyloid phagocytosis. Nanoscale 2021;13:939-52. [PMID: 33479718 DOI: 10.1039/d0nr05958g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD. Drug delivery platforms for neonatal brain injury. J Control Release 2021;330:765-87. [PMID: 33417984 DOI: 10.1016/j.jconrel.2020.12.056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rizk M, Vu J, Zhang Z. Impact of pediatric traumatic brain injury on hippocampal neurogenesis. Neural Regen Res 2021;16:926-33. [PMID: 33229731 DOI: 10.4103/1673-5374.297057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Liaw K, Reddy R, Sharma A, Li J, Chang M, Sharma R, Salazar S, Kannan S, Kannan RM. Targeted systemic dendrimer delivery of CSF-1R inhibitor to tumor-associated macrophages improves outcomes in orthotopic glioblastoma. Bioeng Transl Med 2021;6:e10205. [PMID: 34027092 DOI: 10.1002/btm2.10205] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
14 Liaw K, Sharma R, Sharma A, Salazar S, Appiani La Rosa S, Kannan RM. Systemic dendrimer delivery of triptolide to tumor-associated macrophages improves anti-tumor efficacy and reduces systemic toxicity in glioblastoma. J Control Release 2021;329:434-44. [PMID: 33290796 DOI: 10.1016/j.jconrel.2020.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
15 Sharma A, Liaw K, Sharma R, Spriggs T, Appiani La Rosa S, Kannan S, Kannan RM. Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma. Biomacromolecules 2020;21:5148-61. [PMID: 33112134 DOI: 10.1021/acs.biomac.0c01270] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
16 Zhang Z, Lin YA, Kim SY, Su L, Liu J, Kannan RM, Kannan S. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model. J Neuroinflammation 2020;17:319. [PMID: 33100217 DOI: 10.1186/s12974-020-01984-1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Mitragotri S. Bioengineering & Translational Medicine: Year 2020 in review. Bioeng Transl Med 2020;5:e10178. [PMID: 33005741 DOI: 10.1002/btm2.10178] [Reference Citation Analysis]
18 Sharma A, Liaw K, Sharma R, Thomas AG, Slusher BS, Kannan S, Kannan RM. Targeting Mitochondria in Tumor-Associated Macrophages using a Dendrimer-Conjugated TSPO Ligand that Stimulates Antitumor Signaling in Glioblastoma. Biomacromolecules 2020;21:3909-22. [PMID: 32786523 DOI: 10.1021/acs.biomac.0c01033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
19 Nemeth CL, Tomlinson SN, Sharma R, Sharma A, Kannan S, Kannan RM, Fatemi A. Glial restricted precursor delivery of dendrimer N-acetylcysteine promotes migration and differentiation following transplant in mouse white matter injury model. Nanoscale 2020;12:16063-8. [PMID: 32724988 DOI: 10.1039/c9nr10804a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sharma R, Kambhampati SP, Zhang Z, Sharma A, Chen S, Duh EI, Kannan S, Tso MO, Kannan RM. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury. Journal of Controlled Release 2020;323:361-75. [DOI: 10.1016/j.jconrel.2020.04.036] [Cited by in Crossref: 24] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
21 Khoury ES, Sharma A, Ramireddy RR, Thomas AG, Alt J, Fowler A, Rais R, Tsukamoto T, Blue ME, Slusher B, Kannan S, Kannan RM. Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome. Theranostics 2020;10:5736-48. [PMID: 32483415 DOI: 10.7150/thno.41714] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
22 Liaw K, Zhang F, Mangraviti A, Kannan S, Tyler B, Kannan RM. Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioeng Transl Med 2020;5:e10160. [PMID: 32440565 DOI: 10.1002/btm2.10160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
23 Yousefi M, Narmani A, Jafari SM. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv Colloid Interface Sci 2020;278:102125. [PMID: 32109595 DOI: 10.1016/j.cis.2020.102125] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 25.0] [Reference Citation Analysis]
24 Krishnan V, Mitragotri S. Nanoparticles for topical drug delivery: Potential for skin cancer treatment. Adv Drug Deliv Rev 2020;153:87-108. [PMID: 32497707 DOI: 10.1016/j.addr.2020.05.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 14.5] [Reference Citation Analysis]
25 Dias AP, da Silva Santos S, da Silva JV, Parise-Filho R, Igne Ferreira E, Seoud OE, Giarolla J. Dendrimers in the context of nanomedicine. Int J Pharm 2020;573:118814. [PMID: 31759101 DOI: 10.1016/j.ijpharm.2019.118814] [Cited by in Crossref: 34] [Cited by in F6Publishing: 56] [Article Influence: 11.3] [Reference Citation Analysis]
26 Mitragotri S. Editorial: The launch phase of Bioengineering & Translational Medicine. Bioeng Transl Med 2019;4:e10140. [PMID: 31572798 DOI: 10.1002/btm2.10140] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Nowak M, Helgeson ME, Mitragotri S. Delivery of Nanoparticles and Macromolecules across the Blood–Brain Barrier. Adv Therap 2020;3:1900073. [DOI: 10.1002/adtp.201900073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
28 Yellepeddi VK, Ghandehari H. Pharmacokinetics of oral therapeutics delivered by dendrimer-based carriers. Expert Opinion on Drug Delivery 2019;16:1051-61. [DOI: 10.1080/17425247.2019.1656607] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
29 Nemeth CL, Fine AS, Fatemi A. Translational challenges in advancing regenerative therapy for treating neurological disorders using nanotechnology. Adv Drug Deliv Rev 2019;148:60-7. [PMID: 31100303 DOI: 10.1016/j.addr.2019.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
30 Sharma A, Liaw K, Sharma R, Zhang Z, Kannan S, Kannan RM. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics. Theranostics 2018;8:5529-47. [PMID: 30555562 DOI: 10.7150/thno.29039] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 14.5] [Reference Citation Analysis]